Loading...
•
Mar 31, 2024
Acadia Healthcare Q1 2024 Earnings Report
Acadia Healthcare reported solid financial and operating performance with revenue growth and strategic investments.
Key Takeaways
Acadia Healthcare reported a strong first quarter in 2024, with a 9.1% increase in revenue to $768.1 million. The company saw a 9.2% increase in same facility revenue, driven by a 6.9% increase in revenue per patient day and a 2.2% increase in patient days. Net income attributable to Acadia was $76.4 million, or $0.83 per diluted share, and adjusted EBITDA increased by 14.9% to $173.9 million.
Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023
Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient day of 6.9% and an increase in patient days of 2.2%
Net income attributable to Acadia totaled $76.4 million, or $0.83 per diluted share
Adjusted EBITDA totaled $173.9 million, an increase of 14.9% over the first quarter of 2023
Acadia Healthcare
Acadia Healthcare
Acadia Healthcare Revenue by Geographic Location
Revenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Acadia affirmed its previously announced financial guidance for 2024.
Positive Outlook
- Revenue between $3.18 to $3.25 billion
- Adjusted EBITDA between $730 to $770 million
- Adjusted earnings per diluted share between $3.40 to $3.70
- Interest expense between $110 to $120 million
- Total bed additions, excluding acquisitions, approximately 1,200 beds
Challenges Ahead
- Tax rate between 24.5% to 25.5%
- Depreciation and amortization expense between $150 to $160 million
- Stock compensation expense between $40 to $45 million
- Operating cash flows between $525 to $575 million
- Expansion capital expenditures between $425 to $475 million